Literature DB >> 12466132

Targeted inactivation of the mouse guanylin gene results in altered dynamics of colonic epithelial proliferation.

Kris A Steinbrecher1, Steve A Wowk, Jeffrey A Rudolph, David P Witte, Mitchell B Cohen.   

Abstract

Heat-stable enterotoxin (STa), elaborated by enterotoxigenic Echerichia coli, is a worldwide cause of secretory diarrhea in infants and travelers. Both STa and guanylin, a peptide structurally similar to STa, increase intracellular cGMP levels after binding to the same intestinal receptor, guanylate cyclase C (GC-C). Distinct from its role as an intestinal secretagogue, guanylin may also have a role in intestinal proliferation, as guanylin expression is lost in intestinal adenomas. To determine the function of guanylin in intestinal epithelia, guanylin null mice were generated using a Cre/loxP-based targeting vector. Guanylin null mice grew normally, were fertile and showed no signs of malabsorption. However, the levels of cGMP in colonic mucosa of guanylin null mice were significantly reduced. The colonic epithelial cell migration rate was increased and increased numbers of colonocytes expressing proliferating cell nuclear antigen (PCNA) were present in crypts of guanylin null mice as well. The apoptotic index was similar in guanylin null mice and littermate controls. We conclude from these studies that loss of guanylin results in increased proliferation of colonic epithelia. We speculate that the increase in colonocyte number is related to decreased levels of cGMP and that this increase in proliferation plays a role in susceptibility to intestinal adenoma formation and/or progression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12466132      PMCID: PMC1850912          DOI: 10.1016/S0002-9440(10)64494-X

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  35 in total

1.  The heat-stable enterotoxin-guanylin receptor is expressed in rat hepatocytes and in a rat hepatoma (H-35) cell line.

Authors:  J P Balint; J L Kosiba; M B Cohen
Journal:  J Recept Signal Transduct Res       Date:  1997-07       Impact factor: 2.092

2.  Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene.

Authors:  H Shibata; K Toyama; H Shioya; M Ito; M Hirota; S Hasegawa; H Matsumoto; H Takano; T Akiyama; K Toyoshima; R Kanamaru; Y Kanegae; I Saito; Y Nakamura; K Shiba; T Noda
Journal:  Science       Date:  1997-10-03       Impact factor: 47.728

3.  Interruption of specific guanylyl cyclase signaling pathways.

Authors:  Z Gao; P S Yuen; D L Garbers
Journal:  Adv Second Messenger Phosphoprotein Res       Date:  1997

4.  Disruption of the guanylyl cyclase-C gene leads to a paradoxical phenotype of viable but heat-stable enterotoxin-resistant mice.

Authors:  S Schulz; M J Lopez; M Kuhn; D L Garbers
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

5.  Guanylin, an endogenous ligand for C-type guanylate cyclase, is produced by goblet cells in the rat intestine.

Authors:  Z Li; B Taylor-Blake; A R Light; M F Goy
Journal:  Gastroenterology       Date:  1995-12       Impact factor: 22.682

6.  A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells.

Authors:  F Schwenk; U Baron; K Rajewsky
Journal:  Nucleic Acids Res       Date:  1995-12-25       Impact factor: 16.971

7.  Gene expression profiles in normal and cancer cells.

Authors:  L Zhang; W Zhou; V E Velculescu; S E Kern; R H Hruban; S R Hamilton; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1997-05-23       Impact factor: 47.728

8.  Uroguanylin and guanylin: distinct but overlapping patterns of messenger RNA expression in mouse intestine.

Authors:  T L Whitaker; D P Witte; M C Scott; M B Cohen
Journal:  Gastroenterology       Date:  1997-09       Impact factor: 22.682

9.  Uroguanylin is expressed by enterochromaffin cells in the rat gastrointestinal tract.

Authors:  A Perkins; M F Goy; Z Li
Journal:  Gastroenterology       Date:  1997-09       Impact factor: 22.682

10.  Intestinal adaptation following massive small bowel resection in the mouse.

Authors:  M A Helmrath; W E VanderKolk; G Can; C R Erwin; B W Warner
Journal:  J Am Coll Surg       Date:  1996-11       Impact factor: 6.113

View more
  56 in total

1.  Molecular staging estimates occult tumor burden in colorectal cancer.

Authors:  Alex Mejia; Stephanie Schulz; Terry Hyslop; David S Weinberg; Scott A Waldman
Journal:  Adv Clin Chem       Date:  2010       Impact factor: 5.394

2.  Sex modulates intestinal transformation by the tumor-suppressor GCC.

Authors:  Peng Li; Stephanie Schulz; Giovanni M Pitari; Scott A Waldman
Journal:  Clin Transl Sci       Date:  2008-09       Impact factor: 4.689

3.  Sex modulates intestinal transformation by the tumor-suppressor GCC.

Authors:  Peng Li; Stephanie Schulz; Giovanni M Pitari; Scott A Waldman
Journal:  Clin Transl Sci       Date:  2008-09       Impact factor: 4.689

Review 4.  Regulation and therapeutic targeting of peptide-activated receptor guanylyl cyclases.

Authors:  Lincoln R Potter
Journal:  Pharmacol Ther       Date:  2010-12-24       Impact factor: 12.310

Review 5.  Membrane guanylyl cyclase receptors: an update.

Authors:  David L Garbers; Ted D Chrisman; Phi Wiegn; Takeshi Katafuchi; Joseph P Albanesi; Vincent Bielinski; Barbara Barylko; Margaret M Redfield; John C Burnett
Journal:  Trends Endocrinol Metab       Date:  2006-06-30       Impact factor: 12.015

6.  An enteroendocrine cell-based model for a quiescent intestinal stem cell niche.

Authors:  I R Radford; P N Lobachevsky
Journal:  Cell Prolif       Date:  2006-10       Impact factor: 6.831

Review 7.  GCC signaling in colorectal cancer: Is colorectal cancer a paracrine deficiency syndrome?

Authors:  P Li; J E Lin; G P Marszlowicz; M A Valentino; C Chang; S Schulz; G M Pitari; Scott A Waldman
Journal:  Drug News Perspect       Date:  2009 Jul-Aug

8.  Enterotoxin preconditioning restores calcium-sensing receptor-mediated cytostasis in colon cancer cells.

Authors:  Giovanni M Pitari; Jieru E Lin; Fawad J Shah; Wilhelm J Lubbe; David S Zuzga; Peng Li; Stephanie Schulz; Scott A Waldman
Journal:  Carcinogenesis       Date:  2008-06-19       Impact factor: 4.944

9.  Novel Therapeutics: NSAIDs, Derivatives, and Phosphodiesterases.

Authors:  Heather N Tinsley; Gary A Piazza
Journal:  Curr Colorectal Cancer Rep       Date:  2012-12

10.  Receptor guanylyl cyclase C (GC-C): regulation and signal transduction.

Authors:  Nirmalya Basu; Najla Arshad; Sandhya S Visweswariah
Journal:  Mol Cell Biochem       Date:  2009-12-04       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.